Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Identification of Genetic Markers Modulating Rhythmic Risk Among Patients With Severe Cardiomyopathy

NCT02852018 is registered in ClinicalTrials.gov with Nantes University Hospital as lead sponsor.

NCT NCT02852018
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02852018 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Identification of Genetic Markers Modulating Rhythmic Risk Among Patients With Severe Cardiomyopathy
Lead sponsor
Nantes University Hospital
Phase
Observational
Overall status
Completed
Start date
January 31, 2010
Completion date
November 30, 2017
Enrollment
1,500 (actual)
Sites
18

Conditions

As the registry lists them; a condition with its own page is linked.

cardiomyopathy